|8:45 a.m. - 1:45 p.m.
||Pharmaceutical Exhibitors Available
||UW-Madison Faculty Lecture: Lisa Arkin, MD
"Leveraging COVID toes: mapping an exceptional innate immune response to SARS-CoV-2" "
Interesting Cases from UW-Madison Dermatology
||Interesting Cases from UW-Madison Dermatology
George T. Reizner, MD, Lecture: Bethanee Schlosser, M.D.
|12:30 p.m.||Meeting Adjourned|
|12:35 p.m.-1:35 p.m.
Sponsor Breakout Rooms
|1:15 p.m.-1:45 p.m.||WDS Business Meeting|
|Lisa Arkin, MD is currently the Director of Pediatric Dermatology, an Assistant Professor of Dermatology & Pediatrics and serves as the Co-Director of the Birthmarks and Vascular Anomalies Center (BVAC) at the University of Wisconsin School of Medicine and Public Health. She is currently the chair of the Pediatric Dermatology Research Alliance Early Investigator's Committee, and responsible for creation of programming directed for trainees and junior faculty <7 years out of fellowship.
Her current research involves investigation of patients with so-called "COVID toes," with banked tissue including serial blood, saliva and skin biopsies. The intention of this work is to solidify the genetic and immune signature in these patients to catalyze therapeutics for those at risk for severe COVID.
She also has a Dermatology Foundation-funded project starting this spring to find a precision-based treatment for patients with port wine stains. This project will leverage novel imaging utilizing optical coherence tomography and genotyping to determine more precise treatment parameters for these patients. As part of that project, she and Dr. Beth Drolet are utilizing spatial transcriptomics to map downstream pathways in patients with known GNAQ/GNA11 mutations to elucidate molecular targets for pharmacologic intervention.
Bethanee Schlosser, MD has dedicated her career to advancing the field of women’s skin health and to improving the lives of women and girls through education, clinical care, and investigative research. Dr. Schlosser is an internationally recognized expert in female genital (vulvar) mucosal disorders, acne, rosacea, skin disorders in pregnancy, and excess hair disorders in women. For more than twelve years, Dr. Schlosser served as full-time faculty in the Departments of Dermatology and Obstetrics/Gynecology at Northwestern University, serving as Director of Women’s Skin Health Program, Vulvar Mucosal Specialty Clinic, and Skin Concerns in Pregnancy Clinic. She is currently devoting her time to caring for her immediate and extended family in the context of the COVID pandemic.
UW-Madison Resident Presenters
Participate online live or watch the recording at your convenience.
CME & MOC credit for physicians are available for real-time participation only.
WDS Members: Free
Non-Members: $100, includes 1-year membership
No refunds will be given.
Dana Kader Robb, email@example.com
To receive CME credit, you will need to enroll in Ethos, the MCW CME system. Instructions will be sent via email after registration.
ACCME Accreditation Statement
The activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The Medical College of Wisconsin and the Wisconsin Dermatological Society. The Medical College of Wisconsin is accredited by the ACCME to provide continuing medical education for physicians.
AMA Credit Designation Statement
The Medical College of Wisconsin designates this live activity for a maximum of 3.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Care Professionals
The Medical College of Wisconsin designates this activity for up to 3.25 hours of participation for continuing education for allied health professionals.
Target Audience and Scope of Practice
This program is intended for dermatologists, dermatopathologists, dermatologic surgeons, nurse practitioners, physician assistants, WDS members, and other allied healthcare providers who work with patients that have dermatologic diseases. The secondary target audience is dermatology residents.
To keep dermatology providers abreast of relevant new clinical knowledge and dermatological skills, in order to provide quality medical care for their patients, and improved healthcare outcomes.